Mirum Pharmaceuticals, Inc. MIRM

Latest FY: 2025 Healthcare Biotechnology
Market Price $100.62
Market Cap $6.14B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑54.7% YoY
$521.31M
3-Yr CAGR: 89.1%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑488.0% YoY
$54.87M
FCF Yield: 0.89%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MIRM)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2020: Revenue YoY (-100.0%) is identical to Gross Profit YoY (-100.0%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018
FY 2019 $2.2M $2.2M 0.00% $-39.4M $-39.6M
FY 2020 -100.0% 0.00% $-89.1M $-89.3M -125.3%
FY 2021 $19.1M $1.5M 0.00% $-132.8M $-132.8M -48.7%
FY 2022 $77.1M +302.7% $61.1M 0.00% $-120.1M $-120.4M +9.3%
FY 2023 $186.4M +141.8% $139.3M 0.00% $-70.9M $-71.1M +41.0%
FY 2024 $336.9M +80.8% $255.2M 0.00% $10.3M $9.3M +113.1%
FY 2025 $521.3M +54.7% $421.1M 0.00% $55.8M $54.9M +488.0%
$

Valuation

Market Price $100.62
Market Cap $6.14B
Enterprise Value $5.84B
P/E Ratio N/A
P/B Ratio 19.50
FCF Yield 0.89%
Dividend Yield N/A
Shares Outstanding 60,981,200
%

Profitability & Margins

Gross Margin 80.77%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.62x
Revenue 3-Yr CAGR 89.13%
🛡️

Financial Health & Liquidity

Current Ratio 0.09
Cash Ratio 1.51
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $296.68M
Total Debt N/A
Book Value / Share $5.16
💧

Cash Flow Efficiency

Operating Cash Flow $55.83M
Capital Expenditures (CapEx) $954.00K
Free Cash Flow $54.87M
OCF / Revenue 10.71%
FCF / Revenue 10.53%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $5.16
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $842.81M
Total Liabilities $528.12M
Stockholders' Equity $314.69M
Current Assets $18.14M
Current Liabilities $196.19M